PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics.
作者信息
Mitra-Ghosh Taraswi, Callisto Samuel P, Lamba Jatinder K, Remmel Rory P, Birnbaum Angela K, Barbarino Julia M, Klein Teri E, Altman Russ B
机构信息
Department of Experimental and Clinical Pharmacology, University of Minnesota Minneapolis.
Department of Pharmacotherapy and Translational Research, University of Florida Gainesville, Florida.
出版信息
Pharmacogenet Genomics. 2020 Jun;30(4):81-90. doi: 10.1097/FPC.0000000000000397.
Abstract
摘要
相似文献
1
PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics.药物基因组学知识库总结：拉莫三嗪途径、药代动力学和药效学。
Pharmacogenet Genomics. 2020 Jun;30(4):81-90. doi: 10.1097/FPC.0000000000000397.
2
FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force.美国食品药品监督管理局关于拉莫三嗪心脏效应的安全警告：国际抗癫痫联盟/美国癫痫学会特设工作组的一份咨询意见
Epilepsia Open. 2021 Feb 25;6(1):45-48. doi: 10.1002/epi4.12475. eCollection 2021 Mar.
3
A Population Pharmacokinetic-Pharmacogenetic Model of Lamotrigine in Chinese Children With Epilepsy.拉莫三嗪在中国癫痫儿童中的群体药代动力学-药物遗传学模型
Ther Drug Monit. 2018 Dec;40(6):730-737. doi: 10.1097/FTD.0000000000000563.
4
The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2).抗癫痫药物拉莫三嗪是小鼠和人乳腺癌耐药蛋白（ABCG2）的底物。
Neuropharmacology. 2015 Jun;93:7-14. doi: 10.1016/j.neuropharm.2015.01.015. Epub 2015 Jan 31.
5
Pharmacokinetics, Safety, and Tolerability of Lamotrigine Chewable/Dispersible Tablet Following Repeat-Dose Administration in Healthy Chinese Volunteers.拉莫三嗪咀嚼片/分散片在健康中国志愿者中重复给药后的药代动力学、安全性和耐受性。
Clin Pharmacol Drug Dev. 2018 Aug;7(6):627-633. doi: 10.1002/cpdd.449. Epub 2018 Mar 26.
6
Dosing Recommendations for Lamotrigine in Children: Evaluation Based on Previous and New Population Pharmacokinetic Models.儿童拉莫三嗪剂量推荐：基于既往和新的群体药代动力学模型评估。
J Clin Pharmacol. 2021 May;61(5):677-687. doi: 10.1002/jcph.1791. Epub 2020 Dec 14.
7
Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady-state disposition of lamotrigine in adults with epilepsy.ABCG2 421C＞A 多态性与丙戊酸在成年癫痫患者中对拉莫三嗪稳态分布的影响之间的相互作用。
Br J Clin Pharmacol. 2018 Sep;84(9):2106-2119. doi: 10.1111/bcp.13646. Epub 2018 Jul 8.
8
Incorporating Breastfeeding-Related Variability with Physiologically Based Pharmacokinetic Modeling to Predict Infant Exposure to Maternal Medication Through Breast Milk: a Workflow Applied to Lamotrigine.将与母乳喂养相关的变异性与基于生理学的药代动力学模型相结合，以预测通过母乳中母亲用药对婴儿的暴露：应用于拉莫三嗪的工作流程。
AAPS J. 2021 May 17;23(4):70. doi: 10.1208/s12248-021-00599-5.
9
Impact of P-glycoprotein and breast cancer resistance protein on the brain distribution of antiepileptic drugs in knockout mouse models.P-糖蛋白和乳腺癌耐药蛋白对抗癫痫药物在基因敲除小鼠模型脑内分布的影响。
Eur J Pharmacol. 2013 Jun 15;710(1-3):20-8. doi: 10.1016/j.ejphar.2013.03.049. Epub 2013 Apr 12.
10
Transmembrane signaling in the maltose ABC transporter MalFGK2-E: periplasmic MalF-P2 loop communicates substrate availability to the ATP-bound MalK dimer.麦芽糖ABC转运蛋白MalFGK2-E中的跨膜信号传导：周质中的MalF-P2环将底物可用性传递给ATP结合的MalK二聚体。
J Biol Chem. 2009 Jun 26;284(26):17521-6. doi: 10.1074/jbc.M109.006270. Epub 2009 Apr 24.
引用本文的文献
1
Role of pharmacogenomics for prevention of hypersensitivity reactions induced by aromatic antiseizure medications.药物基因组学在预防芳香族抗癫痫药物引起的过敏反应中的作用。
Front Pharmacol. 2025 Aug 12;16:1640401. doi: 10.3389/fphar.2025.1640401. eCollection 2025.
2
Lamotrigine Therapy: Relation Between Treatment of Bipolar Affective Disorder and Incidence of Stevens-Johnson Syndrome-A Narrative Review of the Existing Literature.拉莫三嗪治疗：双相情感障碍治疗与史蒂文斯-约翰逊综合征发病率之间的关系——现有文献的叙述性综述
J Clin Med. 2025 Jun 10;14(12):4103. doi: 10.3390/jcm14124103.
3
Physiologically Based Pharmacokinetic Modeling to Predict Lamotrigine Exposure in Special Populations to Facilitate Therapeutic Drug Monitoring and Guide Dosing Regimens.基于生理的药代动力学建模以预测特殊人群中拉莫三嗪的暴露量，以促进治疗药物监测并指导给药方案。
Pharmaceuticals (Basel). 2025 Apr 27;18(5):637. doi: 10.3390/ph18050637.
4
Revealing Lingonberry's Neuroprotective Potential in Alzheimer's Disease Through Network Pharmacology and Molecular Docking.通过网络药理学和分子对接揭示越橘在阿尔茨海默病中的神经保护潜力
Int J Mol Sci. 2025 Mar 6;26(5):2363. doi: 10.3390/ijms26052363.
5
Characterization of lamotrigine disposition changes during and after pregnancy in women with epilepsy.癫痫女性孕期及产后拉莫三嗪处置变化的特征分析
Pharmacotherapy. 2025 Jan;45(1):33-42. doi: 10.1002/phar.4640. Epub 2025 Jan 7.
6
Candidate-gene studies related to drug pharmacokinetics, pharmacodynamics, safety, and efficacy in the era of extensive technological developments: could we empower them by more efficient implementation of established epidemiological concepts?在技术飞速发展的时代，与药物药代动力学、药效学、安全性和有效性相关的候选基因研究：我们能否通过更有效地应用既定的流行病学概念来增强其作用？
Croat Med J. 2024 Oct 31;65(5):457-466. doi: 10.3325/cmj.2024.65.457.
7
Molecular mechanisms of Buqing granule for the treatment of diabetic retinopathy: Network pharmacology analysis and experimental validation.补清颗粒治疗糖尿病视网膜病变的分子机制：网络药理学分析与实验验证
World J Diabetes. 2024 Sep 15;15(9):1942-1961. doi: 10.4239/wjd.v15.i9.1942.
8
Pharmacogenetic Variants and Plasma Concentrations of Antiseizure Drugs: A Systematic Review and Meta-Analysis.抗癫痫药物的药物遗传学变异与血药浓度：一项系统评价和荟萃分析。
JAMA Netw Open. 2024 Aug 1;7(8):e2425593. doi: 10.1001/jamanetworkopen.2024.25593.
9
Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet.欧洲药物性肝损伤研究路线图。来自欧洲科学与技术合作组织（COST）行动ProEuroDILINet的一项提议。
Pharmacol Res. 2024 Feb;200:107046. doi: 10.1016/j.phrs.2023.107046. Epub 2023 Dec 28.
10
Identifying the natural products in the treatment of atherosclerosis by increasing HDL-C level based on bioinformatics analysis, molecular docking, and in vitro experiment.基于生物信息学分析、分子对接和体外实验，鉴定通过增加 HDL-C 水平治疗动脉粥样硬化的天然产物。
J Transl Med. 2023 Dec 19;21(1):920. doi: 10.1186/s12967-023-04755-7.
本文引用的文献
1
Expression of clinically relevant drug-metabolizing enzymes along the human intestine and their correlation to drug transporters and nuclear receptors: An intra-subject analysis.沿人体肠道表达的具有临床意义的药物代谢酶及其与药物转运体和核受体的相关性：一项个体内分析。
Basic Clin Pharmacol Toxicol. 2019 Mar;124(3):245-255. doi: 10.1111/bcpt.13137. Epub 2018 Oct 26.
2
Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady-state disposition of lamotrigine in adults with epilepsy.ABCG2 421C＞A 多态性与丙戊酸在成年癫痫患者中对拉莫三嗪稳态分布的影响之间的相互作用。
Br J Clin Pharmacol. 2018 Sep;84(9):2106-2119. doi: 10.1111/bcp.13646. Epub 2018 Jul 8.
3
Retrospective review of paediatric case reports of Stevens-Johnson syndrome and toxic epidermal necrolysis with lamotrigine from an international pharmacovigilance database.对来自国际药物警戒数据库的、使用拉莫三嗪后出现史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的儿科病例报告进行回顾性分析。
BMJ Paediatr Open. 2017 Aug 4;1(1):e000039. doi: 10.1136/bmjpo-2017-000039. eCollection 2017.
4
Rifampin modulation of xeno- and endobiotic conjugating enzyme mRNA expression and associated microRNAs in human hepatocytes.利福平对人肝细胞中外源和内源性结合酶 mRNA 表达及相关 microRNA 的调节作用。
Pharmacol Res Perspect. 2018 Mar 26;6(2):e00386. doi: 10.1002/prp2.386. eCollection 2018 Apr.
5
Are doses of lamotrigine or levetiracetam adjusted during pregnancy?拉莫三嗪或左乙拉西坦的剂量在孕期是否需要调整？
Epilepsia Open. 2017 Nov 27;3(1):86-90. doi: 10.1002/epi4.12086. eCollection 2018 Mar.
6
Establishing Transcriptional Signatures to Differentiate PXR-, CAR-, and AhR-Mediated Regulation of Drug Metabolism and Transport Genes in Cryopreserved Human Hepatocytes.建立转录特征以区分 PXR、CAR 和 AhR 介导的冷藏人原代肝细胞中药物代谢和转运基因的调控。
J Pharmacol Exp Ther. 2018 May;365(2):262-271. doi: 10.1124/jpet.117.247296. Epub 2018 Feb 12.
7
UGT polymorphisms and lamotrigine clearance during pregnancy.孕期UGT基因多态性与拉莫三嗪清除率
Epilepsy Res. 2018 Feb;140:199-208. doi: 10.1016/j.eplepsyres.2018.01.011. Epub 2018 Jan 31.
8
Association of and Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population.泰国人群中**和**等位基因与拉莫三嗪诱导的皮肤药物不良反应的关联。
（原文中“Association of and Alleles”这里两个“and”之间应该有具体基因名称等内容缺失，我按正常格式翻译了，但请你确认下原文准确内容）
Front Pharmacol. 2017 Nov 29;8:879. doi: 10.3389/fphar.2017.00879. eCollection 2017.
9
The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs.抗癫痫药物新使用者发生史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的风险。
Epilepsia. 2017 Dec;58(12):2178-2185. doi: 10.1111/epi.13925. Epub 2017 Oct 13.
10
HLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions.HLA-A*24:02作为抗癫痫药物所致皮肤不良反应的常见危险因素。
Neurology. 2017 Jun 6;88(23):2183-2191. doi: 10.1212/WNL.0000000000004008. Epub 2017 May 5.
Zotero 插件